Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabea Schoeler

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Psychological Medicine|May 5, 2020
Cyber-victimisation and mental health in young people: a co-twin control studyJessie R Baldwin, Ziada Ayorech, Fruhling V Rijsdijk, et al.
European Journal of Epidemiology|January 13, 2022
Protecting against researcher bias in secondary data analysis: challenges and potential solutionsJessie R Baldwin, Jean-Baptiste Pingault, Tabea Schoeler, et al.
Addiction Biology|July 25, 2020
Identifying risk factors involved in the common versus specific liabilities to substance use: A genetically informed approachEleonora Iob, Tabea Schoeler, Charlotte M Cecil, et al.
The Lancet. Psychiatry|May 5, 2023
Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UKSagnik Bhattacharyya, Tabea Schoeler, Marta Di Forti, et al.
Schizophrenia Research|October 17, 2020
Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samplesSagnik Bhattacharyya, Tabea Schoeler, Rashmi Patel, et al.
Neuroscience and Biobehavioral Reviews|December 11, 2017
Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysisMathilde Antoniades, Tabea Schoeler, Joaquim Radua, et al.
The Lancet. Psychiatry|July 15, 2017
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
Psychological Medicine|April 3, 2018
Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-upTabea Schoeler, Delphine Theobald, Jean-Baptiste Pingault, et al.
Psychiatry Research|May 19, 2017
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
BMC Cardiovascular Disorders|December 13, 2023
Cannabis use and atherosclerotic cardiovascular disease: a Mendelian randomization studyRoxane de La Harpe, Tabea Schoeler, Christian W Thorball, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Psychological Medicine|May 5, 2020
Cyber-victimisation and mental health in young people: a co-twin control studyJessie R Baldwin, Ziada Ayorech, Fruhling V Rijsdijk, et al.
European Journal of Epidemiology|January 13, 2022
Protecting against researcher bias in secondary data analysis: challenges and potential solutionsJessie R Baldwin, Jean-Baptiste Pingault, Tabea Schoeler, et al.
Addiction Biology|July 25, 2020
Identifying risk factors involved in the common versus specific liabilities to substance use: A genetically informed approachEleonora Iob, Tabea Schoeler, Charlotte M Cecil, et al.
The Lancet. Psychiatry|May 5, 2023
Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UKSagnik Bhattacharyya, Tabea Schoeler, Marta Di Forti, et al.
Schizophrenia Research|October 17, 2020
Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samplesSagnik Bhattacharyya, Tabea Schoeler, Rashmi Patel, et al.
Neuroscience and Biobehavioral Reviews|December 11, 2017
Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysisMathilde Antoniades, Tabea Schoeler, Joaquim Radua, et al.
The Lancet. Psychiatry|July 15, 2017
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
Psychological Medicine|April 3, 2018
Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-upTabea Schoeler, Delphine Theobald, Jean-Baptiste Pingault, et al.
Psychiatry Research|May 19, 2017
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
BMC Cardiovascular Disorders|December 13, 2023
Cannabis use and atherosclerotic cardiovascular disease: a Mendelian randomization studyRoxane de La Harpe, Tabea Schoeler, Christian W Thorball, et al.
Pageof 4